Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

NCT02245230 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT02245230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02245230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2015
Completion date
December 31, 2023
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, hypertension, essential